ArticlePharmacoEconomics - open2025

Semaglutide 2.4 mg versus Liraglutide 3 mg for the Treatment of Obesity in Greece: A Short-Term Cost-Effectiveness Analysis.

Panagiotis Papantoniou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.